FindMyKOL
Clinical trialNCT06409364RecruitingPhase 2Interventional

FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage

SponsorThe George InstituteEnrollment524Aneurysmal Subarachnoid Hemorrhage
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A multi-centre, prospective, blinded, randomised clinical trial of fludrocortisone compared with placebo in patients presenting with aneurysmal subarachnoid haemorrhage. The study aim is to determine if early administration of enteral fludrocortisone in aneurysmal subarachnoid haemorrhage reduce death and dependency at six months.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • John Hunter Hospital

    New Lambton Heights, New South Wales, Australia

    Andrew ChowTorg Westerlund
    Not, yet, recruiting
  • Nepean Hospital

    Penrith, New South Wales, Australia

    Ian SeppeltIdunn Morris
    Recruiting
  • Prince of Wales Hospital

    Randwick, New South Wales, Australia

    Gavin Salt
    Not, yet, recruiting
  • Royal North Shore Hospital

    St Leonards, New South Wales, Australia

    Anthony DelaneyCelia BradfordChristopher AndersonLachlan DonaldsonTessa Garside
    Not, yet, recruiting
  • Westmead Hospital

    Westmead, New South Wales, Australia

    David Bowen
    Not, yet, recruiting
  • Wollongong Hospital

    Wollongong, New South Wales, Australia

    Matthew Mac Partlin
    Not, yet, recruiting
  • Royal Brisbane Women'S Hospital

    Brisbane, Queensland, Australia

    Jeremy CohenJudith Bellapart-Rubio
    Not, yet, recruiting
  • Gold Coast University Hospital

    Gold Coast, Queensland, Australia

    James McCullough
    Recruiting
  • Townsville Hospital

    Townsville, Queensland, Australia

    Sananta Dash
    Not, yet, recruiting
  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

    Kyle White
    Not, yet, recruiting
  • Royal Hobart Hospital

    Hobart, Tasmania, Australia

    Andrew Turner
    Not, yet, recruiting
  • Monash Medical Centre

    Clayton, Victoria, Australia

    Christopher ShawMak Wei-YunWisam Al-BassamYahya Shehabi
    Not, yet, recruiting
  • St Vincent'S Hospital (melbourne)

    Fitzroy, Victoria, Australia

    Humphrey (George) Walker
    Not, yet, recruiting
  • the Alfred Hospital

    Melbourne, Victoria, Australia

    Andrew UdyDashiell GantnerKhaled El-KhawasRosalind Lindy JeffreeToby JeffcoteVanessa Carnegie
    Not, yet, recruiting
New Zealand
  • Auckland City Hospital

    Auckland, New Zealand

    Chris HandsLaura Tincknell
    Not, yet, recruiting
  • Wellington Hospital

    Wellington, New Zealand

    Jason Wright
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fludrocortisone →Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Aug 2025
Primary completion
31 Jul 2029
Completion
31 Jul 2030
Last update posted
16 Dec 2025
Registered enrollment
524
Registry id
NCT06409364
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.